Markets
Will the NIH implement the proposed changes to its grant review process by February 2027?
Yes0%No0%
Loading...
About this market
This market resolves to Yes if the National Institutes of Health (NIH) officially implements the proposed changes to their grant review process, as described in recent news, by February 28, 2027. The changes involve moving away from transparent numerical scores to a few broad categories like 'Most competitive', 'Competitive', and 'Not discussed'.
Rules
- Market closes at 2/28/2027.
- Logic weighted resolution applies.
The odds seem way too optimistic for the NIH to have this all sorted by February 2027. Historically, these kinds of procedural changes take years, not months. Plus, the last significant overhaul from them took about three years. I'd put the actual chance of implementation closer to 30 percent, not the current spread.
Rationale:The comment provides a well-reasoned perspective based on historical context regarding the NIH's procedural changes, which supports a high score for Fact Check. It avoids logical fallacies and is directly relevant to the market question, though it does contain some emotional appeal regarding the perceived optimism of the odds. The weights reflect the importance of factual accuracy and logical reasoning in this analysis.
Current odds imply there's a solid chance of the NIH making those changes, but the historical average for such proposals getting implemented isn't very high. Feels overpriced to me based on past data.
Rationale:The comment presents a reasonable analysis of the current odds and historical data regarding NIH proposals, which supports a mostly accurate fact check score. It avoids logical fallacies and is relevant to the market question, though it could benefit from more specific data to strengthen its claims. The weights reflect a balanced focus on factual accuracy and logical reasoning, given the reliance on historical data and odds.
I think the price is too high given the recent delays in NIH decision-making; they have a history of being slow to adapt, and I wouldn’t count on these changes happening by that deadline.
Rationale:The comment accurately reflects concerns about the NIH's historical decision-making speed, which is a relevant factor in predicting the implementation of changes by February 2027. While the claim about delays is mostly accurate, it lacks specific evidence, leading to a slightly lower score for Fact Check. The comment is logically sound and directly addresses the market question, with a reasonable balance of logic and emotional appeal, justifying the chosen weights.
tbh, I think the chances of NIH actually changing their grant review process by early 2027 are pretty low. They've been pretty set in their ways for a while now, and even if they do propose changes, getting everyone on board takes forever. The market seems overly optimistic here; I’m not convinced they’ll pull it off that quickly.
Rationale:The comment presents a mostly accurate perspective on the NIH's historical resistance to change, which is a reasonable deduction but lacks specific evidence to fully support the claim. It is logically sound and directly addresses the market question, indicating skepticism about the proposed changes. The weights reflect a balanced emphasis on logical reasoning and relevance, with a slight focus on factual accuracy due to the lack of specific data backing the claims.
i'm not sure about this one. the changes seem way too ambitious, and getting it all sorted out by february feels unrealistic. there’s always resistance when it comes to big shifts like this, especially in such a huge org like the nih. i’d be surprised if they pull it off that quick. what do you all think?
Rationale:The comment expresses skepticism about the NIH's ability to implement ambitious changes by February 2027, which is a relevant concern. While it lacks specific factual evidence, it reflects a reasonable perspective on organizational change. The weights emphasize relevance and the absence of major logical fallacies, while fact-checking is less critical due to the subjective nature of the opinion expressed.
this feels like a classic case of overhyping. the nih has a history of dragging its feet on changes, and the proposed review process tweaks aren't exactly revolutionary. even if they do happen, february 2027 seems way too optimistic. i'm leaning towards no and think the price should reflect that.
Rationale:The comment presents a mostly accurate view of the NIH's historical behavior regarding changes, which supports a skeptical outlook on the proposed changes. While it does not contain major logical fallacies, it leans slightly on emotional appeal regarding the optimism of the timeline. The weights reflect a balanced focus on relevance and logical reasoning, with less emphasis on strict factual verification since the claims are based on historical context rather than specific data. Overall, the comment is relevant and provides a reasoned perspective on the market question.
Not sure why the market thinks these changes are a lock. The NIH has been super slow with anything big lately; I wouldn't be surprised if they push it back again. Seems like a risky bet to me.
Rationale:The comment expresses skepticism about the NIH's ability to implement changes by the deadline, which is relevant to the market question. While it reflects a reasonable concern based on the NIH's past performance, it lacks specific evidence to support the claim of slowness, leading to a slightly lower fact-check score. The comment is logically sound with no major fallacies, but it does rely somewhat on emotional appeal regarding the perceived risk of the bet. Weights were adjusted to reflect the importance of relevance and logical reasoning in this context.
not sure why the odds are so low on this, the NIH has been talking about these changes for ages and they really need to fix their grant review process.
Rationale:The comment reflects a reasonable perspective on the NIH's ongoing discussions about grant review process changes, which is mostly accurate but lacks specific evidence to support the claim about the urgency of the need for these changes. The relevance to the market question is high, as it directly addresses the perceived likelihood of the proposed changes being implemented. The weights reflect a balance between factual accuracy and relevance, with a slight emphasis on the need for logical reasoning over emotional appeal.
the spreads here are weirdly wide for something so likely to happen. the NIH usually moves pretty fast with this kind of stuff. I'm leaning towards yes, but the odds aren't reflecting that.
Rationale:The comment provides a personal assessment of the market odds and the NIH's typical responsiveness, which is mostly accurate but lacks specific evidence to support the claim about the NIH's speed. It is relevant to the market question, as it discusses the likelihood of the NIH implementing changes. The weights reflect a balance between relevance and the need for factual support, given the subjective nature of the comment.
It seems almost absurd to think that the NIH could overhaul such a complex and entrenched process by early next year; given the political landscape and usual bureaucratic pace, I would be surprised if they even make significant progress by then.
Rationale:The comment presents a reasonable skepticism about the NIH's ability to implement changes quickly, reflecting on the political and bureaucratic context. While it lacks specific evidence to support the claims, it is mostly accurate and relevant to the market question. The weights reflect a balance between relevance and the need for logical reasoning, given the speculative nature of the comment.